Modulation of the interleukin-6 signalling pathway and incidence rates of atherosclerotic events and all-cause mortality: analyses from the Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS)

European Heart Journal
Paul M RidkerRobert J Glynn

Abstract

Canakinumab, a monoclonal antibody targeting interleukin (IL)-1β, reduces rates of recurrent cardiovascular events without lowering lipids. It is uncertain, however, to what extent these beneficial cardiovascular outcomes are mediated through interleukin-6 (IL-6) signalling, an issue with substantial pathophysiologic consequences and therapeutic implications. A total of 4833 stable atherosclerosis patients in the Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS) had IL-6 levels measured before randomization and after treatment with placebo or one of three doses of canakinumab (50 mg, 150 mg, or 300 mg) given subcutaneously once every 3 months. Participants were followed for up to 5 years (median follow-up 3.7 years). Compared with those allocated to placebo, CANTOS participants receiving canakinumab who achieved on-treatment IL-6 levels below the study median value of 1.65 ng/L experienced a 32% reduction in major adverse cardiovascular events [MACE, multivariable adjusted hazard ratio (HRadj) 0.68, 95% confidence interval (CI) 0.56-0.82; P < 0.0001], a 30% reduction in MACE plus the additional endpoint of hospitalization for unstable angina requiring urgent revascularization (MACE+, HRadj 0.70, 95% CI 0.59-0.84;...Continue Reading

References

Jan 2, 2007·The American Journal of Cardiology·Won-Young LeeElizabeth Barrett-Connor
Feb 8, 2011·Biochimica Et Biophysica Acta·Jürgen SchellerStefan Rose-John
Mar 17, 2012·Lancet·UNKNOWN IL6R Genetics Consortium Emerging Risk Factors CollaborationJohn Danesh
Mar 17, 2012·Lancet·UNKNOWN Interleukin-6 Receptor Mendelian Randomisation Analysis (IL6R MR) ConsortiumJuan Pablo Casas
Jun 7, 2014·Circulation Research·Peter LibbyEdward A Fisher
Jun 22, 2017·The New England Journal of Medicine·Siddhartha JaiswalBenjamin L Ebert
Aug 29, 2017·The New England Journal of Medicine·Paul M RidkerUNKNOWN CANTOS Trial Group
Sep 17, 2017·Circulation·Göran K Hansson
Oct 27, 2017·Journal of the American Heart Association·Lori B Daniels
Oct 28, 2017·Journal of the American College of Cardiology·Peter Libby
Dec 9, 2017·Circulation Research·Borja Ibañez, Valentin Fuster

❮ Previous
Next ❯

Citations

Aug 31, 2018·European Heart Journal·Roland Klingenberg, Thomas F Lüscher
Dec 12, 2018·European Heart Journal·Thomas F Lüscher
Nov 21, 2018·International Reviews of Immunology·Antonis A ManolisAntonis S Manolis
Jan 3, 2019·European Heart Journal·Željko ReinerUlf Landmesser
Feb 20, 2019·European Heart Journal·John G F ClelandPiotr Ponikowski
Mar 1, 2019·Arteriosclerosis, Thrombosis, and Vascular Biology·Peter Libby, Brendan M Everett
Apr 3, 2019·International Journal of Molecular Sciences·Antonella FiordelisiDaniela Sorriento
May 17, 2019·Arteriosclerosis, Thrombosis, and Vascular Biology·John E Mindur, Filip K Swirski
May 24, 2019·European Heart Journal·Esther LutgensChristian Weber
Jul 12, 2019·Arteriosclerosis, Thrombosis, and Vascular Biology·Hafid Ait-OufellaAlain Tedgui
Sep 1, 2019·Current Pharmaceutical Design·Nathalie SattaSabrina Pagano
May 6, 2019·American Journal of Physiology. Heart and Circulatory Physiology·Christina AlterJürgen Schrader
Nov 30, 2019·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Surya DharmaSunil V Rao
Jan 30, 2020·International Journal of Molecular Sciences·Iwona ŚwiątkiewiczPam R Taub
Mar 3, 2020·Metabolic Syndrome and Related Disorders·Katharina LechnerRonald M Krauss
Mar 7, 2020·Current Opinion in Lipidology·Michael H Davidson
Mar 17, 2020·European Heart Journal·Patrick R LawlerPaul M Ridker
Mar 17, 2020·Future Medicinal Chemistry·Yee-Hung Chan, Dipak P Ramji
Mar 24, 2020·Annals of Internal Medicine·Mounica VallurupalliPaul M Ridker
Apr 24, 2020·Circulation Research·Antonio AbbateCharles A Dinarello
Apr 4, 2020·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Roland von KänelBrent T Mausbach
Apr 30, 2019·Current Opinion in Cardiology·Alberto J Lorenzatti, Maria Luz Servato
May 14, 2020·Circulation. Genomic and Precision Medicine·Marios K GeorgakisUNKNOWN INVENT Consortium,CHARGE Inflammation Working Group
Apr 22, 2020·The Journal of Immunology : Official Journal of the American Association of Immunologists·Yang YangScott R Johnstone
Sep 11, 2019·European Heart Journal·Luigi M BiasucciGiovanna Liuzzo
Jul 3, 2019·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Anna-Isabelle KälschErnst Malle
May 20, 2020·The Journal of Clinical Investigation·Mabruka AlfaidiA Wayne Orr
May 30, 2020·Cellular & Molecular Immunology·Xinwen LinHong Tang
Jun 25, 2020·Journal of Periodontology·Kenneth S Kornman
Jun 13, 2020·The Journal of Clinical Endocrinology and Metabolism·Charlotte D C C van der HeijdenNiels P Riksen
Dec 19, 2018·International Journal of Molecular Sciences·Stella BernardiBruno Fabris
Jun 12, 2019·Nature Reviews. Cardiology·Priscilla Y Hsue, David D Waters

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Cardiology Journals

Discover the latest cardiology research in this collection of the top cardiology journals.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.